$GLAND - New breakout

Gland Pharma is attempting a major breakout above a long-term resistance zone that has capped price since 2024, making this a structurally important move. Multiple failed breakout attempts in the past make the current expansion significant, especially if price sustains above the ₹2,180–2,220 zone with follow-through volume. A successful hold above this range could mark the beginning of a fresh medium-term uptrend and potential re-rating after a prolonged consolidation phase. $GLAND